Page 461 - Read Online
P. 461

Citterio et al. Plast Aesthet Res 2020;7:41  I  http://dx.doi.org/10.20517/2347-9264.2020.29                                     Page 5 of 20

               Table 1. Summary of available evidence for periodontal regeneration with mesenchymal stem cells
                              Bone regeneration                PL                       Cementum
                BMMSC Effective in grade III furcation defects,   Effective in grade III furcation defects;  Effective in grade III furcation defects
                       but bone fill is not complete;  Conflicting results; effective only
                       Ineffective when used without bone   associated with bone substitutes
                       substitutes
                ASC    Effective in extraction sockets  Effective in surgically created intrabony  Effective in surgically created intrabony
                                                   defects                    defects
                PDLSC  Effective in fenestration; No added   Effective in fenestration; More effective  Effective in fenestration; added
                       benefit associated with non reservable   than BMMSC;   benefit associated with non reservable
                       membranes in fenestrations; Effective   Effective in intrabony defects with better  membranes in fenestrations: Effective
                       in intrabony defects only using bone   results using bone substitutes  in intrabony defects with better results
                       substitutes                                            using bone substitutes
                DPSC   Effective in extraction sockets; Improve  Improve regeneration in intrabony   Improve regeneration in intrabony
                       bone regeneration in intrabony defects  defects        defects
                DFPC   Improve effects of PDLSC    Improve effects of PDLSC   Improve effects of PDLSC
                SHED   Increased bone volume in intrabony   Increased PL fibers in intrabony defects  Increased in intrabony defects
                       defects
                SCAP   Increased bone volume in intrabony   Increased in intrabony defects compared  Increased in intrabony defects compared
                       defects compared to saline  to saline                  to saline
               BMMSC: bone marrow mesenchymal stem cell; ASC: adipose-derived stem cell; PDLSC: periodontal ligament stem cell; DPSC: dental
               pulp stem cell; DFPC: dental follicle precursor cell; SHED: stem cell from human exfoliated teeth; SCAP: stem cell from apical papilla

                       [65]
                                                                                     [66]
               methods ; the way of delivery and implantation in combination with membranes ; and biomaterials [67,68]
               or bioactive molecules [69,70] .
               Briefly, age has no effect on the possibility of isolating and culturing stem cells, but showed a statistically
               significant effect on the procedure outcome. Cells harvested from donors over 60 years of age had an over
               50% failure rate. On the contrary, in younger donors (≤ 60 years old), the failure rate ranged between 14%
                                                                                               [64]
               and 22%. No effect of gender was found, with similar success rates for male and female donors .
               It has been suggested that the site of harvesting can also influence the outcomes of the cell therapy
               procedures, according to the differences found in stem cells of the same lineage but taken from different
                                                              [64]
               niches. More studies are needed to confirm this finding .

               The culture and the expansion protocols used to amplify the numbers of transplanted cells are a variable
               that can alter the “stemness” properties of the stem cells. No clear protocol has been developed yet for the
               treatment of MSCs, in particular oral ones. We know that under certain conditions (i.e., particular culture
               mediums) we can alter the differentiation path, favoring a subset of cells that can increase the successful
                                          [71]
               outcomes of our cell treatments ; however, further research is needed to better understand and guide this
               process.


               Finally, the protocols wherewith these cells are administered can have a positive or negative effect on the
               final result. Cell therapy can be administered on a scaffold base or on a scaffold-free delivery system. The
               first one implies the use of a biomaterial, usually calcium-based, a membrane, or a combination of the
               two. The rational behind the use of biomaterials and membranes is the need for blood clot stability in
               order to reach its formation and maturation. When the conformation of the periodontal defect is not firm
               enough, biomaterials and membranes can make up for the lack of stability and enhance the regeneration
               process. It has been shown, also in vivo, that different materials have different effects, either positive or
                                                               [30]
               negative, on the non-cell-based regeneration techniques . Similarly, these effects have been found in cell-
               based regenerative therapies, with promising results from beta-TCP [46,72-74] , hyaluronic acid [75,76] , and nano
               designed materials [77-79] .
   456   457   458   459   460   461   462   463   464   465   466